Page last updated: 2024-09-03

2-pyrrolino-dox and Experimental Mammary Neoplasms

2-pyrrolino-dox has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Groot, K; Halmos, G; Nagy, A; Schally, AV; Szepeshazi, K1
Nagy, A; Schally, AV; Szepeshazi, K1

Other Studies

2 other study(ies) available for 2-pyrrolino-dox and Experimental Mammary Neoplasms

ArticleYear
Targeted cytotoxic luteinizing hormone releasing hormone (LH-RH) anlalogs inhibit growth of estrogen independent MXT mouse mammary cancers in vivo by decreasing cell proliferation and inducing apoptosis.
    Anti-cancer drugs, 1997, Volume: 8, Issue:10

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Division; Cell Survival; DNA, Neoplasm; Doxorubicin; Estrogens; Female; Gonadotropin-Releasing Hormone; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Hormone-Dependent; Pyrroles; Receptors, LHRH

1997
Effective treatment of advanced estrogen-independent MXT mouse mammary cancers with targeted cytotoxic LH-RH analogs.
    Breast cancer research and treatment, 1999, Volume: 56, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Division; Doxorubicin; Drug Delivery Systems; Estrogens; Female; Gonadotropin-Releasing Hormone; Growth Inhibitors; Injections, Intravenous; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Hormone-Dependent; Pyrroles

1999